BARICITINIB vs BEBTELOVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BARICITINIB vs BEBTELOVIMAB: Safety Overview
| Metric | BARICITINIB | BEBTELOVIMAB |
|---|---|---|
| Total FAERS Reports | 8,108 | 1,383 |
| Deaths Reported | 717 | 20 |
| Death Rate | 8.8% | 1.4% |
| Hospitalizations | 2,498 | 224 |
| Average Patient Age | 58.2 yrs | 56.4 yrs |
| % Female Patients | 67.9% | 66.9% |
| FDA Approval Date | Aug 8, 2025 | N/A |
| Manufacturer | Eli Lilly and Company | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |